Scott Wardwell
Scott Wardwell publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, Chronic Myeloid Leukemia Treatments and Lung Cancer Research Studies.
- World rank
- #558,585 of 7,710,434 ranked researchers
- Rank in United States
- #192,807 of 1,627,098
- Works
- 85
- Citations
- 5.9k
- Citations per work
- 69.1
What does Scott Wardwell research?
Scott Wardwell's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4755.7%
- Medicine4755.7%
- Everything else2125.2%
- Life Sciences1619.1%
- 1Molecular Biology19% of their works
- 2Oncology17% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Hematology12% of their works
- 5Genetics7% of their works
- 6Rheumatology5% of their works
Research topics
Which keywords describe Scott Wardwell's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Prognostic Factors, ALK Inhibitors, EGFR Mutations, BCR-ABL, Imatinib and Chemotherapy.
- Topoisomerases
- FGF21
- Hypereosinophilic Syndrome
- mTOR
- Genomic Aberrations
- Small-Cell Lung Cancer
- Signaling
- Chemotherapy
- BCR-ABL
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Prognostic Factors
- EGFR Mutations
- Imatinib
- Cancer
- Genomic Profiles
- Chronic Lymphocytic Leukemia
- PI3K/AKT pathway
- Fusion Genes
- DNA
- Fibroblast Growth Factor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Clinical Trials242 topics
- Targeted Therapy242 topics
- Prognostic Factors162 topics
- ALK Inhibitors151 topic
- EGFR Mutations151 topic
- BCR-ABL141 topic
- Imatinib141 topic
- Chemotherapy132 topics
- Cancer112 topics
- Signaling112 topics
- Genomic Profiles91 topic
- Small-Cell Lung Cancer91 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- PI3K/AKT pathway71 topic
- mTOR71 topic
- Fusion Genes61 topic
- Hypereosinophilic Syndrome61 topic
- DNA41 topic
- FGF2141 topic
- Fibroblast Growth Factor41 topic
- Topoisomerases41 topic
Where does Scott Wardwell work?
Scott Wardwell's main affiliation in the publication record is Ariadne Diagnostics (United States), United States.
How many publications and citations does Scott Wardwell have?
OpenAlex counts 85 works and 5,872 citations for Scott Wardwell, an h-index of 25, ranking #558,585 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Scott Wardwell. Posts are plain text and can be reported.